Strong opioids and constipation;Stark wirksame opioidanalgetika und obstipation

Schmerz

Volumn 19, Issue 3, 2005, Pages 214-219

  Schwarzer, A ^a,b,c   Nauck, F ^b   Klaschik, E ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Malteser Krankenhaus Bonn Hardtberg EV   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Cancer pain; Constipation; Opioids; Palliative care

Indexed keywords

BUPRENORPHINE; FENTANYL; HYDROMORPHONE; LEVOMETHADONE; METHADONE; MORPHINE; MORPHINE 6 GLUCURONIDE; OPIATE; OXYCODONE;

CANCER PALLIATIVE THERAPY; CHRONIC PAIN; CONSTIPATION; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROLYTE DISTURBANCE; FLUID INTAKE; HUMAN; REVIEW;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTESTINES; LONG-TERM CARE; NAUSEA; NEOPLASMS; PAIN MEASUREMENT; PAIN, INTRACTABLE; PALLIATIVE CARE; RECEPTORS, OPIOID, MU; TREATMENT OUTCOME; VOMITING;

EID: 21644482833     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-004-0325-3     Document Type: Review

References (54)

1. Ahmedzai S, Brooks D (1997) Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage 13(5):254-261
2. Allan L, Hays H, Jensen NH, de Waroux BL, Bolt M, Donald R, Kalso E (2001) Randomized crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 322:1154-1158
3. Burks TF (1978) Gastrointestinal pharmacology. Ann Rev Pharmacol Toxicol 16:15-31
4. Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, Mercadante S, Pasternak G, Ventafridda V (2001) Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19:2542-2554
5. Daeninck PJ, Bruera E (1999) Reduction in constipation and laxative requirements following opioid rotation to methadone: a report of four cases. J Pain Symptom Manage 18(4):303-309
6. Donner B, Zenz M, Tryba M, Strumpf M (1996) Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain 64(3):527-534
7. Donner B, Zenz M, Strumpf M, Raber M (1998) Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage 15(3):168-175
8. Freye E (2001) Opioide in der Medizin. Springer, Berlin Heidelberg New York
9. Freye E, Latasch L (2003) Toleranzentwicklung unter Opioidgabe: Molekulare Mechanismen und klinische Bedeutung. Anästhesiol Intensivmed Notfallmed Schmerzther 38:14-26
10. Gralow I (2002) Cancer pain: an update of pharmacological approaches in pain therapy. Curr Opin Anesthesiol 15:555-561
11. Grilo RM, Bertin P, Scotto di Fazano C, Coyral D, Bonnet C, Vergne P, Trèves R (2002) Opioid rotation in the treatment of joint pain. A review of 67 cases. Joint Bone Spine 69:491-494
12. Grond S, Zech D, Diefenbach C, Bischoff A (1994) Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage 9(6):372-382
13. Grond S, Radbruch L, Meuser T, Loick G, Sabatowski R, Lehmann KA (1999) High-dose tramadol in comparison to low-dose morphine for cancer pain relief. J Pain Symptom Manage 18(3):174-179
14. Grond S, Radbruch L, Lehmann KA (2000) Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clin Pharmacokinet 38(1):59-89
15. Heiskanen T, Kalso E (1997) Controlled-release oxycodone and morphine in cancer related pain. Pain 73(1):37-45
16. Jurna I, Baldauf J (1993) Retardiert freigesetztes Naloxon oral: Aufhebung der Obstipation durch orales Morphin ohne Beseitigung der Analgesie. Schmerz 7:314-321
17. Klaschik E (2003) Symptome in der Palliativmedizin: Obstipation. Schlütersche, Hannover
18. Klaschik E, Nauck F, Ostgathe C (2003) Constipation - modern laxative therapy. Support Care Cancer 11(11):679-685
19. Kopf A, Janson W, Stein C (2003) Anwendungsmöglichkeiten für Opioide bei chronischem Nichttumorschmerz. Anaesthesist 52:103-114
20. Latasch L, Zimmermann M, Eberhardt B, Jurna I (1997) Aufhebung einer Morphin-induzierten Obstipation durch orales Naloxon. Anaesthesist 46:191-194
21. Lehmann KA (2002) Analgetische Therapie mit Opioiden. Uni-Med, Bremen
22. Liu M, Wittbrodt E (2002) Low-dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Symptom Manage 23(1):48-53
23. Mancini I, Bruera E (1998) Constipation in advanced cancer patients. Support Care Cancer 6(4):356-364
24. Mancini I, Hanson J, Neumann CM, Bruera E (2000) Opioid typ and other clinical predictors of laxative dose in advaced cancer patients: a retrospective study. J Palliat Med 3(1):49-56
25. Megens AA, Artois K, Vermeire J, Meert T, Awouters FH (1998) Comparison of the analgesic and intestinal effects of fentayl and morphine in rats. J Pain Symptom Manage 15(4):253-257
26. Mercadante S (1999) Opioid rotation for cancer pain: rationale and clinical aspects. Cancer 86(9):1856-1866
27. Mercadante S, Casuccio A, Fulfaro F, Groff L, Boffi R, Villari P, Gebbia V, Ripamonti C (2001) Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol 19(11):2898-2904
28. Moriarty M, McDonald CJ, Miller AJ (1999) A randomized crossover comparison of controlled release hydromorphone tablets with controlled release morphine tablets in patients with cancer pain. J Clin Res 2:1-8
29. Müller-Lissner S (1992) Nebenwirkungen von Laxantien. Z Gastroenterol 30:418-427
30. Mullican WS, Lacy JR, TRAMAP-ANAG-006 Study Group (2001) Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: a comperative trial. Clin Ther 23(9):1429-1445
31. Nasar MA, McLeavy MA, Knox J (1986) An open study of sub-lingual buprenorphine in the treatment of chronic pain in the elderly. Curr Med Res Opin 10(4):251-255
32. Nugent M, Davis C, Books D, Ahmedzai SH (2001) Long-term observations of patients receiving transdermal fentanyl after a randomized trial. J Pain Symptom Manage 21(5):385-391
33. O'Mahony S, Coyle N, Payne R (2001) Current management of opioid-related side effects. Oncology 15(1):61-77
34. Ostgathe C, Nauck F, Radbruch L, Klaschik E (2003) Schmerztherapie auf den Palliativstationen in Deutschland - Erfolge und Defizite in der Versorgung. Z Palliativmed 4:49-54
35. Payne R, Mathias SD, Pasta DJ, Wanke LA, Williams R, Mahmoud R (1998) Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine. J Clin Oncol 16:1588-1593
36. Quigley C, Wiffen P (2003) A systematic review of hydromorphone in acute and chronic pain. J Pain Symptom Manage 25:169-178
37. Radbruch L (2003) Buprenorphine TDS: use in daily practice, benefits for patients. Int J Clin Pract [suppl 133]:19-22
38. Radbruch L, Sabatowski R, Loick G, Kulbe C, Kasper M, Grand S, Lehmann KA (2000) Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med 14(2):111-119
39. Radbruch L, Sabatowski R, Petzke F, Brunsch-Radbruch A, Grond S, Lehmann KA (2001) Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients. Palliat Med 15:309-321
40. Radbruch L, Nauck F (2002) Morphin und andere Opioide in der Tumorschmerztherapie. Die Empfehlungen der EAPC. Deutschsprachige Übersetzung des Artikels: Hanks GW, deConno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Roca i Casas J, Säwe J, Twycross R, Ventafridda V (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84(5):587-593.
41. Schmerz 16:186-193
42. Robbie DS (1979) A trial of sublingual buprenorphine in cancer pain. Br J Clin Pharmacol 7 [suppl 3]:315S-317S
43. Stewart WF, Liberman JN, Sandler RS, Woods MS, Sternhagen A, Chee E, Lipton RB, Farup CE (1999) Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to socioeconomic features. Am J Gastroenterol 94:3530-3539
44. Strohmeyer G (1992) Erkrankungen des Dickdarms. In: Siegenthaler W, Kaufmann W, Hornbostel H, Waller HD (Hrsg) Lehrbuch der inneren Medizin. Thieme, Stuttgart
45. Strumpf M (2001) Krebsschmerz. In: Zenz M, Jurna I (Hrsg) Lehrbuch der Schmerztherapie. Wissenschaftliche Verlagsgesellschaft, Stuttgart
46. Strumpf M, Zenz M (2001) Stufenschema, Betä ubungsmittelverschreibungsverordnung (BtMVV). In: Zenz M, Jurna I (Hrsg) Lehrbuch der Schmerztherapie. Wissenschaftliche Verlagsgesellschaft, Stuttgart
47. Sykes NP (1998) The relationship between opiod use and laxative use in terminally ill cancer patients. Palliat Med 12(5):375-382
48. Sykes NP (1998) Constipation and diarrhoea. In: Doyle D, Hanks GWC, MacDonald N (eds) Oxford textbook of palliative medicine, 2nd edn. Oxford University Press, Oxford
49. Twycross RG, Harcourt J (1991) The use of laxatives at a palliative care center. Palliat Med 5:27-33
50. Wong JO, Chiu GL, Tsao CJ, Chang CL (1997) Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain. Acta Anaesthesiol Sin 35(1):25-32
51. World Health Organization (1996) Cancer pain relief, 2nd edn. WHO office of publication, Genf
52. Yuan CS, Foss JF, O'Connor M, Moss J, Roizen MF (1998) Gut motility and transit changes in patients receiving long-term methadone maintenance. J Clin Pharmacol 38(10):931-935
53. Zenz M (1995) Taschenbuch der Schmerztherapie. Wissenschaftliche Verlagsgesellschaft, Stuttgart
54. Zenz M (2003) Opioide, Alte Mythen - neue Mythen - Zukunft. Anaesthesist 52:100-101